Spanish drugmaker Almirall has lined up its new CEO following the departure of Peter Guenter, who left to lead Merck KGaA’s healthcare unit earlier this month ...

Almirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash.

At close: April 10 at 5:35:19 PM GMT+2 ...

At close: April 16 at 4:00:00 PM EDT ...